Mauro David J
- SEC CIK
- 0001621172
No open-market purchases or sales filed in the past year.
Current role at each company
- RXRX Recursion Pharmaceuticals, Inc.Chief Medical Officeras of Nov 19, 2024
- CDAK Codiak BioSciences, Inc.Chief Medical Officeras of Jan 26, 2023
- PRLD Prelude Therapeutics IncChief Medical Officeras of Oct 6, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mauro David J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PRLD Prelude Therapeutics Inc
Chief Medical Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2021 (view filing) | Oct 5 | 1 day | Mauro David JChief Medical Officer | SSale | −15.0K | $30.96 | −$464.3K | −100.0%0 after | 3 lots |
| Sep 9, 2021 (view filing) | Sep 7 | 2 days | Mauro David JChief Medical Officer | SSale | −15.0K | $36.68 | −$550.3K | −100.0%0 after | 3 lots |
| Aug 9, 2021 (view filing) | Aug 5 | 4 days | Mauro David JChief Medical Officer | SSale | −15.0K | $31.09 | −$466.4K | −100.0%0 after | 4 lots |
| Jul 8, 2021 (view filing) | Jul 6 | 2 days | Mauro David JChief Medical Officer | SSale | −15.0K | $27.48 | −$412.1K | −100.0%0 after | 3 lots |